IHC scores are shown in Figure 2D. Thus, glutamine-scarce tumor regions are characterized by a more reverse Warburg-like metabotype exhibiting stronger MCT1 expression, while in glutamine-rich regions, MCT4 expression prevails. The gene discussed is SLC16A1; the disease is neoplasm.